News

PharmiWeb21m
The Weight Loss Drugs Market: Trends, Challenges, and Opportunities
Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...
Fangzhou and Novo Nordisk link on chronic disease management
The joint effort will focus on providing patients with medication guidance, reminders, tracking of efficacy and health education.
Canadian market to see generic Ozempic and Wegovy come January. What does that mean for Hamilton?
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. Investors looking to strike ...
UNILAD18h
New investigation launched after health experts find potentially fatal side effect of taking weight loss drugs
A study reveals potentially fatal side effects of GLP-1 drugs, that people are using to lose weight. It’s well known that ...
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been fil ...
HIMS SECURITIES NEWS: Did Hims & Hers Health, Inc. (NYSE:HIMS) Commit Securities Fraud? Contact BFA Law By August 25 Class Action Deadline
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...